Last week Samsung SDS revealed that it’s exploring using blockchain for the pharmaceutical supply chain, according to South Korean pharma publication Yakup. The report states the first use cases will use IoT to ensure drugs are kept at the correct temperature during transport.
But the trials aim to reduce manual paperwork, automate logistics tracking and verify the authenticity of collections and returns, amongst others. These processes should enable a speedy drug recall should it be needed.
In November, Samsung SDS aims to start the pilots lasting three to six months and aims to commercialize the service in May to June 2021, including globally.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
